Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion Services

NACompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

August 10, 2018

Study Completion Date

August 10, 2018

Conditions
Medical Abortion, Complete or Unspecified, Without Complication
Interventions
DEVICE

Multi-level pregnancy test

Study participants will be instructed to perform a baseline MLPT immediately prior to administering the first dose of abortion medication and a second MLPT one week later to ascertain the follow-up hCG range. Any woman who obtains a stable or increasing hCG result, when comparing the baseline test result with the follow-up test result, will be instructed to contact safe2choose. Any woman who obtains a decrease in her hCG range, when comparing the baseline test result with the follow-up test result, will be informed that her abortion was a success and she is no longer pregnant.

Trial Locations (1)

10010

Gynuity Health Projects, New York

All Listed Sponsors
collaborator

safe2choose

UNKNOWN

lead

Gynuity Health Projects

OTHER

NCT03207880 - Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion Services | Biotech Hunter | Biotech Hunter